Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1996 1
1997 1
1999 1
2004 2
2005 1
2006 3
2007 2
2009 2
2011 2
2012 2
2013 1
2014 6
2015 2
2016 1
2017 2
2018 4
2019 2
2022 1
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Juvenile idiopathic arthritis.
Espinosa M, Gottlieb BS. Espinosa M, et al. Among authors: gottlieb bs. Pediatr Rev. 2012 Jul;33(7):303-13. doi: 10.1542/pir.33-7-303. Pediatr Rev. 2012. PMID: 22753788 Review.
Autoantibodies Recognizing Specificity Protein 4 Co-occur With Anti-Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile Myositis.
Sherman MA, Pak K, Pinal-Fernandez I, Flegel WA, Targoff IN, Miller FW, Rider LG, Mammen AL; Childhood Myositis Heterogeneity Collaborative Study Group. Sherman MA, et al. Arthritis Rheumatol. 2023 Sep;75(9):1668-1677. doi: 10.1002/art.42512. Epub 2023 Jul 19. Arthritis Rheumatol. 2023. PMID: 36996276
Clinical Features and Immunogenetic Risk Factors Associated With Additional Autoantibodies in Anti-Transcriptional Intermediary Factor 1γ Juvenile-Onset Dermatomyositis.
Sherman MA, Yang Q, Gutierrez-Alamillo L, Pak K, Flegel WA, Mammen AL, Rider LG, Casciola-Rosen LA; Childhood Myositis Heterogeneity Collaborative Study Group. Sherman MA, et al. Arthritis Rheumatol. 2024 Apr;76(4):631-637. doi: 10.1002/art.42768. Epub 2024 Jan 30. Arthritis Rheumatol. 2024. PMID: 38059274
Pediatric Rheumatology Care and Outcomes Improvement Network's Quality Measure Set to Improve Care of Children With Juvenile Idiopathic Arthritis.
Bingham CA, Harris JG, Qiu T, Gilbert M, Vora SS, Yildirim-Toruner C, Ferraro K, Lovell DJ, Taylor J, Mannion ML, Weiss JE, Laxer RM, Shishov M, Oberle EJ, Gottlieb BS, Lee TC, Pan N, Burnham JM, Fair DC, Batthish M, Hazen MM, Spencer CH, Morgan EM; Pediatric Rheumatology Care and Outcomes Improvement Network. Bingham CA, et al. Among authors: gottlieb bs. Arthritis Care Res (Hoboken). 2023 Dec;75(12):2442-2452. doi: 10.1002/acr.25168. Epub 2023 Jul 13. Arthritis Care Res (Hoboken). 2023. PMID: 37308458
Paediatric rheumatologists do not score the physician's global assessment of juvenile idiopathic arthritis disease activity in the same way.
Backström M, Tarkiainen M, Gottlieb BS, Trincianti C, Qiu T, Morgan E, Lovell DJ, Bovis F, Löyttyniemi E, Ruperto N, Vähäsalo P, Consolaro A. Backström M, et al. Among authors: gottlieb bs. Rheumatology (Oxford). 2023 Oct 3;62(10):3421-3426. doi: 10.1093/rheumatology/kead151. Rheumatology (Oxford). 2023. PMID: 37004166 Free PMC article.
Race, Income, and Disease Outcomes in Juvenile Dermatomyositis.
Phillippi K, Hoeltzel M, Byun Robinson A, Kim S; Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry Investigators. Phillippi K, et al. J Pediatr. 2017 May;184:38-44.e1. doi: 10.1016/j.jpeds.2017.01.046. Epub 2017 Mar 3. J Pediatr. 2017. PMID: 28410093 Free PMC article.
42 results